Baxter International, Inc. (BAX)
25.30
-0.35
(-1.36%)
USD |
NYSE |
Oct 23, 16:00
25.30
0.00 (0.00%)
After-Hours: 20:00
Baxter International Enterprise Value : 19.76B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 19.76B |
| October 22, 2026 | 19.94B |
| October 21, 2026 | 19.45B |
| October 20, 2026 | 19.35B |
| October 19, 2026 | 19.60B |
| October 16, 2026 | 19.75B |
| October 15, 2026 | 20.00B |
| October 14, 2026 | 19.50B |
| October 13, 2026 | 19.55B |
| October 12, 2026 | 19.49B |
| October 09, 2026 | 19.27B |
| October 08, 2026 | 19.04B |
| October 07, 2026 | 19.07B |
| October 06, 2026 | 19.27B |
| October 05, 2026 | 19.20B |
| October 02, 2026 | 18.82B |
| October 01, 2026 | 18.90B |
| September 30, 2026 | 19.09B |
| September 29, 2026 | 18.82B |
| September 28, 2026 | 18.82B |
| September 25, 2026 | 18.76B |
| September 24, 2026 | 18.82B |
| September 23, 2026 | 18.82B |
| September 22, 2026 | 18.92B |
| September 21, 2026 | 18.53B |
| Date | Value |
|---|---|
| September 18, 2026 | 18.47B |
| September 17, 2026 | 18.58B |
| September 16, 2026 | 18.84B |
| September 15, 2026 | 18.94B |
| September 14, 2026 | 19.02B |
| September 11, 2026 | 18.98B |
| September 10, 2026 | 19.18B |
| September 09, 2026 | 19.29B |
| September 08, 2026 | 19.53B |
| September 04, 2026 | 20.03B |
| September 03, 2026 | 19.90B |
| September 02, 2026 | 19.97B |
| September 01, 2026 | 19.85B |
| August 31, 2026 | 20.12B |
| August 28, 2026 | 20.19B |
| August 27, 2026 | 20.09B |
| August 26, 2026 | 20.38B |
| August 25, 2026 | 20.27B |
| August 24, 2026 | 20.38B |
| August 21, 2026 | 20.30B |
| August 20, 2026 | 20.33B |
| August 19, 2026 | 20.45B |
| August 18, 2026 | 20.09B |
| August 17, 2026 | 20.08B |
| August 14, 2026 | 20.50B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| DexCom, Inc. | 28.87B |
| Becton, Dickinson & Co. | 70.12B |
| Abbott Laboratories | 207.10B |
| Boston Scientific Corp. | 78.32B |
| ICU Medical, Inc. | 5.156B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 135.00M |
| Revenue (Quarterly) | 2.96B |
| Total Expenses (Quarterly) | 2.825B |
| EPS Diluted (Quarterly) | 0.2432 |
| Gross Profit Margin (Quarterly) | 33.55% |
| Profit Margin (Quarterly) | 4.56% |
| Earnings Yield | -7.62% |
| Operating Earnings Yield | 4.95% |
| Normalized Earnings Yield | -1.627 |